Drug Cos. Question FDA Off-Label Communications Guidance
Recent guidance from the Food and Drug Administration addressing medical product companies' communications to healthcare providers about off-label uses of approved treatments goes too far, pharmaceutical and medical device companies said...To view the full article, register now.
Already a subscriber? Click here to view full article